Regeneron Pharma (NASDAQ:REGN) reported first quarter earnings that missed analysts' expectations on Tuesday and revenue that fell short of forecasts.
The firm reported earnings per share of $4.45 on revenue of $1.71B. Analysts polled by anticipated EPS of $5.48 on revenue of $1.77B. That compared to EPS of $4.67 on revenue of $1.51B in the same period a year earlier. The company had reported EPS of $6.84 on revenue of $1.93B in the previous quarter.
Regeneron Pharma follows other major Healthcare sector earnings this month
On April 16, J&J reported first quarter EPS of $2.1 on revenue of $20.02B, compared to forecasts of EPS of $2.04 on revenue of $19.61B.
Pfizer earnings Beat analysts' expectations on April 30, with first quarter EPS of $0.85 on revenue of $13.12B. analysts expected EPS of $0.75 on revenue of $12.99B
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
